AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
11.36
+0.08 (0.71%)
At close: Sep 2, 2026, 4:00 PM EDT
11.28
-0.08 (-0.70%)
Pre-market: Sep 3, 2026, 4:00 AM EDT
AbCellera Biologics Employees
AbCellera Biologics had 562 employees as of December 31, 2025. The number of employees decreased by 34 or -5.70% compared to the previous year.
Employees
562
Change (1Y)
-34
Growth (1Y)
-5.70%
Revenue / Employee
$117,740
Profits / Employee
-$292,982
Market Cap
3.68B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 562 | -34 | -5.70% |
| Dec 31, 2024 | 596 | 10 | 1.71% |
| Dec 31, 2023 | 586 | 91 | 18.38% |
| Sep 30, 2023 | 630 | 155 | 32.63% |
| Jun 30, 2023 | 590 | 140 | 31.11% |
| Mar 31, 2023 | 525 | 125 | 31.25% |
| Dec 31, 2022 | 495 | 109 | 28.24% |
| Sep 30, 2022 | 475 | 115 | 31.94% |
| Jun 30, 2022 | 450 | 148 | 49.01% |
| Mar 31, 2022 | 400 | 194 | 94.17% |
| Dec 31, 2021 | 386 | 180 | 87.38% |
| Sep 30, 2021 | 360 | 186 | 106.90% |
| Jun 30, 2021 | 302 | 128 | 73.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Telix Pharmaceuticals | 1,184 |
| Iovance Biotherapeutics | 975 |
| Arcus Biosciences | 601 |
| Denali Therapeutics | 507 |
| uniQure | 221 |
| Relay Therapeutics | 202 |
| IDEAYA Biosciences | 145 |
ABCL News
- 12 hours ago - AbCellera to Present at the Cantor Global Healthcare Conference on September 9, 2026 - Business Wire
- 8 days ago - AbCellera rises 17.0% - TheFly
- 8 days ago - AbCellera rises 10.7% - TheFly
- 21 days ago - AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants - Business Wire
- 22 days ago - AbCellera announces $200M common stock, warrants offering - TheFly
- 22 days ago - AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - Business Wire
- 22 days ago - AbCellera price target raised to $30 from $12 at Truist - TheFly
- 23 days ago - AbCellera price target raised to $25 from $13 at JonesResearch - TheFly